Autologous Transplantation of SM/C-2.6+ Satellite Cells Transduced with Micro-dystrophin CS1 cDNA by Lentiviral Vector into mdx Mice.

Duchenne muscular dystrophy (DMD) is a lethal muscle disorder caused by mutations in the dystrophin gene. Transplantation of autologous myogenic cells genetically corrected ex vivo is a possible treatment for this disorder. In order to test the regenerative efficiency of freshly isolated satellite cells, we purified quiescent satellite cells from limb muscles of 8-12-week-old green fluorescent protein-transgenic (GFP-Tg) mice using SM/C-2.6 (a recently developed monoclonal antibody) and flow cytometry. Freshly isolated satellite cells were shown to participate in muscle regeneration more efficiently than satellite cell-derived myoblasts passaged in vitro do, when transplanted into tibialis anterior (TA) muscles of 8-12-week-old cardiotoxin-injected C57BL/6 mice and 5-week-old dystrophin-deficient mdx mice, and analyzed at 4 weeks after injection. Importantly, expansion of freshly isolated satellite cells in vitro without passaging had no detrimental effects on their regenerative capacity. Therefore we directly isolated satellite cells from 5-week-old mdx mice using SM/C-2.6 antibody and cultured them with lentiviral vectors expressing micro-dystrophin CS1. The transduced cells were injected into TA muscles of 5-week-old mdx mice. At 4 weeks after transplantation, the grafted cells efficiently contributed to regeneration of mdx dystrophic muscles and expressed micro-dystrophin at the sarcolemma. These results suggest that there is potential for lentiviral vector-mediated ex vivo gene therapy for DMD.

• Publication year

  2007

• Venue

  Molecular Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.mt.6300295PMID 28182889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up.

  2007cited by this paper
• Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.

  2007cited by this paper
• Dystrophin Expression in Muscles of Duchenne Muscular Dystrophy Patients After High-Density Injections of Normal Myogenic Cells

  2006cited by this paper
• Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

  2006cited by this paper
• Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

  2005cited by this paper
• Li, S, Kimura, E, Fall, BM, Reyes, M, Angello, JC, Welikson, R et al.. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther 12: 1099-1108

  2005cited by this paper
• Myoblast transfer therapy: is there any light at the end of the tunnel?

  2005cited by this paper
• Direct Isolation of Satellite Cells for Skeletal Muscle Regeneration

  2005cited by this paper
• Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin

  2005cited by this paper
• Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody.

  2004cited by this paper
• Muscle reconstitution by muscle satellite cell descendants with stem cell-like properties

  2004cited by this paper
• Cellular and molecular regulation of muscle regeneration.

  2004cited by this paper
• AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype.

  2004cited by this paper
• Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts.

  2004cited by this paper
• Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells.

  2004cited by this paper
• Muscle satellite cells adopt divergent fates

  2004cited by this paper
• Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.

  2004cited by this paper
• Resetting the Problem of Cell Death Following Muscle‐Derived Cell Transplantation: Detection, Dynamics and Mechanisms

  2003cited by this paper
• Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

  2003cited by this paper
• Dose effect relationship between the number of normal progenitor muscle cells grafted in mdx mouse skeletal striated muscle and the number of dystrophin-positive fibres.

  2003cited by this paper
• Correction of the Dystrophic Phenotype by In Vivo Targeting of Muscle Progenitor Cells

  2003cited by this paper
• Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice.

  2002cited by this paper
• Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans.

  2002cited by this paper
• Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene.

  2002cited by this paper
• Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy

  2002cited by this paper
• Identification of a novel population of muscle stem cells in mice

  2002cited by this paper
• Effect of Injecting Primary Myoblasts Versus Putative Muscle-Derived Stem Cells on Mass and Force Generation in mdx Mice

  2002cited by this paper
• A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications

  2002cited by this paper
• Problems and solutions in myoblast transfer therapy

  2001cited by this paper
• Why Do Cultured Transplanted Myoblasts Die in Vivo? DNA Quantification Shows Enhanced Survival of Donor Male Myoblasts in Host Mice Depleted of CD4+ and CD8+ Cells or NK1.1+ Cells

  2000cited by this paper
• α1-Syntrophin Gene Disruption Results in the Absence of Neuronal-type Nitric-oxide Synthase at the Sarcolemma but Does Not Induce Muscle Degeneration*

  1999cited by this paper
• Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell–like Properties as the Myogenic Source

  1999cited by this paper
• A Third-Generation Lentivirus Vector with a Conditional Packaging System

  1998cited by this paper
• Development of a Self-Inactivating Lentivirus Vector

  1998cited by this paper
• Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells.

  1997cited by this paper
• The fate of individual myoblasts after transplantation into muscles of DMD patients

  1997cited by this paper
• Satellite cell proliferative compartments in growing skeletal muscles.

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Yields of muscle from myogenic cells implanted into young and old mdx hosts

  1996cited by this paper
• Myoblast transfer in the treatment of Duchenne's muscular dystrophy.

  1995cited by this paper
• Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

  1994cited by this paper
• Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin.

  1994cited by this paper
• Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers.

  1994cited by this paper
• Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

  1994cited by this paper
• A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin

  1993cited by this paper
• Duchenne muscular dystrophy--Meryon's disease.

  1993cited by this paper
• Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

  1993cited by this paper
• Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice.

  1993cited by this paper
• Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

  1992cited by this paper
• Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

  1991cited by this paper

• Transplantation of Cultured Myoblasts Into Intact Skeletal Muscle and Analysis of Muscle Contraction Force in Mice Model

  2025cites this paper
• Achieving myoblast engraftment into intact skeletal muscle via extracellular matrix

  2025cites this paper
• Extraocular muscle stem cells exhibit distinct cellular properties associated with non-muscle molecular signatures

  2023cites this paper
• Metabolic Changes during In Vivo Maturation of PSC-Derived Skeletal Myogenic Progenitors

  2023cites this paper
• Développement des modèles de culture cellulaire de muscle en 3D : de nouvelles opportunités pour les productions animales

  2023cites this paper
• Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration

  2022cites this paper
• Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice

  2022cites this paper
• Assessment of Muscle Function Following hiPSC‐Derived Myoblast Transplantation in Dystrophic Mice

  2022cites this paper
• Tubastatin A maintains adult skeletal muscle stem cells in a quiescent state ex vivo and improves their engraftment ability in vivo

  2022cites this paper
• Firearms-related skeletal muscle trauma: pathophysiology and novel approaches for regeneration

  2021cites this paper
• 3D in vitro models of skeletal muscle: myopshere, myobundle and bioprinted muscle construct

  2021cites this paper
• Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.

  2021cites this paper
• Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions

  2020cites this paper
• Prostaglandin EP2 receptor downstream of Notch signaling inhibits differentiation of human skeletal muscle progenitors in differentiation conditions

  2020cites this paper
• A Multi-angled Approach to Discover and Improve Skeletal Muscle Stem Cell Therapies

  2019cites this paper
• Gene Correction of Limb Girdle Muscular Dystrophy Type 2A Patient-Specific Induced Pluripotent Stem Cells

  2019cites this paper
• Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies

  2019cites this paper
• Late-onset megaconial myopathy in mice lacking group I Paks

  2019cites this paper
• Mutation-Based Therapeutic Strategies for Duchenne Muscular Dystrophy: From Genetic Diagnosis to Therapy

  2019cites this paper
• Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.

  2019cites this paper
• Skeletal muscle stem cells in comfort and stress

  2018cites this paper
• Recapitulation of Extracellular LAMININ Environment Maintains Stemness of Satellite Cells In Vitro

  2018cites this paper
• Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy

  2018cites this paper
• The roles of muscle stem cells in muscle injury, atrophy and hypertrophy.

  2018cites this paper
• Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors

  2018cites this paper
• Overview of Cell Types Capable of Contributing to Skeletal Muscle Repair and Regeneration

  2018cites this paper
• Personalized gene and cell therapy for Duchenne Muscular Dystrophy.

  2018cites this paper
• Skeletal muscle generated from induced pluripotent stem cells - induction and application

  2017cites this paper
• SOX7 Is Required for Muscle Satellite Cell Development and Maintenance

  2017cites this paper
• Human myogenic reserve cells are quiescent stem cells that contribute to muscle regeneration after intramuscular transplantation in immunodeficient mice

  2017cites this paper
• Notch ligands regulate the muscle stem-like state ex vivo but are not sufficient for retaining regenerative capacity

  2017cites this paper
• Technical advantage of recombinant collagenase for isolation of muscle stem cells

  2017cites this paper
• Stem Cell Therapy in Muscle Degeneration

  2017cites this paper
• Stem Cell-Based Therapy for Duchenne Muscular Dystrophy

  2016cites this paper
• mouse diaphragm mdx muscular dystrophy in the Nitric oxide donors improve prednisone effects on

  2016cites this paper
• Emerging Gene Correction Strategies for Muscular Dystrophies: Scientific Progress and Regulatory Impact

  2016cites this paper
• Retinoic acid maintains human skeletal muscle progenitor cells in an immature state

  2016cites this paper
• Cell-Surface Protein Profiling Identifies Distinctive Markers of Progenitor Cells in Human Skeletal Muscle

  2016cites this paper
• Lineage Plasticity and Regenerative Potential of Adult Muscle Stem Cells: Investigation of Satellite Cell Direct-Reprogramming and Pericyte Self-Renewal

  2016cites this paper
• Enhancement of Satellite Cell Transplantation Efficiency by Leukemia Inhibitory Factor

  2016cites this paper
• Frontiers in Skeletal Muscle Wasting, Regeneration and Stem Cells

  2016influential citation
• Pro‐Insulin‐Like Growth Factor‐II Ameliorates Age‐Related Inefficient Regenerative Response by Orchestrating Self‐Reinforcement Mechanism of Muscle Regeneration

  2015cites this paper
• Pharyngeal Satellite Cells Undergo Myogenesis Under Basal Conditions and Are Required for Pharyngeal Muscle Maintenance

  2015cites this paper
• A muscle stem cell for every muscle: variability of satellite cell biology among different muscle groups

  2015cites this paper
• Gene and cell therapies for muscular dystrophies

  2015cites this paper
• The influence of Notch over-stimulation on muscle stem cell quiescence versus proliferation, and on muscle regeneration

  2015cites this paper
• Myospheres Are Composed of Two Cell Types: One That Is Myogenic and a Second That Is Mesenchymal

  2015cites this paper
• Concise Review: Quiescence in Adult Stem Cells: Biological Significance and Relevance to Tissue Regeneration

  2015cites this paper
• Barriers in contribution of human mesenchymal stem cells to murine muscle regeneration.

  2015cites this paper
• Pax3-induced expansion enables the genetic correction of dystrophic satellite cells

  2015cites this paper
• Adult skeletal muscle stem cells.

  2015cites this paper
• Adult Stem Cells: Adult Skeletal Muscle Stem Cells

  2014cites this paper
• Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength

  2014cites this paper
• Ex Vivo Gene Editing of the Dystrophin Gene in Muscle Stem Cells Mediated by Peptide Nucleic Acid Single Stranded Oligodeoxynucleotides Induces Stable Expression of Dystrophin in a Mouse Model for Duchenne Muscular Dystrophy

  2014cites this paper
• Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle

  2014cites this paper
• Molecular targets to treat muscular dystrophies.

  2014cites this paper
• Regulation of Muscle Stem Cell Quiescent and Undifferentiated State: Roles of Hesr1 and Hesr3 Genes

  2013cites this paper
• Neue Behandlungsansätze bei erblich bedingten Myopathien

  2013cites this paper
• Isolation, characterization, and molecular regulation of muscle stem cells

  2013cites this paper
• Repair or replace? Exploiting novel gene and cell therapy strategies for muscular dystrophies

  2013cites this paper
• Induction of muscle regeneration by RNA‐mediated mitochondrial restoration

  2012cites this paper
• Advances in Lentiviral Vector-based Cell Therapy with Mesenchymal Stem Cells

  2012cites this paper
• Clone‐derived human AF‐amniotic fluid stem cells are capable of skeletal myogenic differentiation in vitro and in vivo

  2012cites this paper
• Further Development of a Tissue Engineered Muscle Repair Construct In Vitro for Enhanced Functional Recovery Following Implantation In Vivo in a Murine Model of Volumetric Muscle Loss Injury

  2012cites this paper
• Muscle Satellite Cells and Duchenne Muscular Dystrophy

  2012cites this paper
• The emerging biology of muscle stem cells: Implications for cell-based therapies

  2012cites this paper
• Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases.

  2011cites this paper
• Effects of transforming growth factor-beta (TGF-β1) on satellite cell activation and survival during oxidative stress

  2011cites this paper
• Analysis of S/MAR vectors for gene therapy in muscle

  2011cites this paper
• Cell therapy for muscular dystrophies: advances and challenges

  2011cites this paper
• Lentiviral vector delivery of shRNA into cultured primary myogenic cells: a tool for therapeutic target validation.

  2011cites this paper
• Housekeeping gene expression in myogenic cell cultures from neurodegeneration and denervation animal models.

  2011cites this paper
• Current advances in cell therapy strategies for muscular dystrophies

  2011cites this paper
• Muscle Fiber Type-Predominant Promoter Activity in Lentiviral-Mediated Transgenic Mouse

  2011influential citation
• Progress and Challenges in AAV-Mediated Gene Therapy for Duchenne Muscular Dystrophy

  2011cites this paper
• Long-Term Contribution of Human Bone Marrow Mesenchymal Stromal Cells to Skeletal Muscle Regeneration in Mice

  2011cites this paper
• Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm.

  2011cites this paper
• An adult tissue-specific stem cell in its niche: a gene profiling analysis of in vivo quiescent and activated muscle satellite cells.

  2010cites this paper
• Gene therapy for muscle disease.

  2010cites this paper
• Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.

  2010cites this paper
• Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression.

  2010cites this paper
• Gene Therapy for Muscular Dystrophies: Progress and Challenges

  2010cites this paper
• Are Human and Mouse Satellite Cells Really the Same?

  2010cites this paper
• Skeletal muscle as a paradigm for regenerative biology and medicine.

  2009cites this paper
• Exon‐skipping therapy for Duchenne muscular dystrophy

  2009cites this paper
• Gene therapy for muscular dystrophy: current progress and future prospects

  2009cites this paper
• Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis.

  2008cites this paper